Our patient had RCC and CD3+, CD8+, CD57+, CD56− T-LGLL and was not known to be severely immunocompromised; hence, she requires investigation for conditions that may predispose her to disseminated NTM infection. The gene discussed is CD8A; the disease is renal cell carcinoma.